Time-dependent association between mean platelet volume and gynecological cancer risk in a large healthcare-based cohort
Open Access
- 11 November 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1934415
Abstract
Background: Gynecological cancers remain a major public health concern worldwide, highlighting the need for accessible biomarkers for early risk assessment. This study aimed to investigate the association between routine clinical laboratory parameters and the risk of incident gynecological cancers in a large healthcare-based cohort. Methods: We conducted a retrospective cohort study including 187, 861 women from the Clinical Center of the University of Debrecen between 2007 and 2023. Baseline laboratory parameters were defined as the median of measurements recorded in the entry year. Incident gynecological cancers were identified using International Classification of Diseases (ICD) codes. Time-to-event analyses were performed using Kaplan-Meier methods and Cox proportional hazards models, incorporating time-varying coefficients to address violations of proportionality. Results: During a median follow-up of approximately 10 years (IQR 6–14 years; maximum follow-up 16 years), 1, 036 incident gynecological cancer cases were identified, corresponding to a crude proportion of 0.55%. Higher baseline mean platelet volume (MPV) was significantly associated with increased cancer risk; however, this relationship was strongly time-dependent. MPV showed little or inverse association in early follow-up but demonstrated progressively increasing hazard ratios over time. This pattern remained robust after adjustment for age, red cell distribution width (RDW), and C-reactive protein (CRP). RDW exhibited a time-dependent association with stronger effects early in follow-up that attenuated over time, while age showed a consistent positive association with cancer risk. Conclusion: In this large healthcare-based cohort, higher baseline MPV was associated with an increased long-term risk of incident gynecological cancer, and the association strengthened with longer follow-up. These findings represent adjusted epidemiological associations that may be affected by residual confounding and should not be interpreted as causal.Keywords
This publication has 47 references indexed in Scilit:
- The role of hematological biomarkers as diagnostic tool in pre-cancerous patientsDiscover Oncology, 2026
- Tumor-mediated remote regulation of peripheral blood plateletsCell Biology and Toxicology, 2025
- Blood hypercoagulability and thrombosis mechanisms in cancer patients -A brief reviewHeliyon, 2024
- Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A reviewCancer Medicine, 2024
- The impact of platelets on the metastatic potential of tumour cellsHeliyon, 2024
- Mean platelet volume as a potential biomarker for survival outcomes in ovarian clear cell carcinomaInternational Journal of Clinical Oncology, 2023
- Clinical application of red cell distribution width, mean platelet volume, and cancer antigen 125 detection in endometrial cancerJournal of Clinical Laboratory Analysis, 2020
- The Platelet Lifeline to Cancer: Challenges and OpportunitiesCancer Cell, 2018
- The Epidemiology of Endometrial and Ovarian CancerHematology/Oncology Clinics of North America, 2012
- Modeling Survival Data: Extending the Cox Model2000